Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study

BACKGROUND: We report long-term safety and immunogenicity of Takeda’s tetravalent dengue vaccine candidate (TAK-003) in healthy children and adults living in dengue-endemic areas in Puerto Rico, Columbia, Singapore, and Thailand. METHODS: In part 1 of this phase 2, randomized, placebo-controlled tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Sirivichayakul, Chukiat, Barranco-Santana, Elizabeth A, Rivera, Inés Esquilín, Kilbury, Jennifer, Raanan, Marsha, Borkowski, Astrid, Papadimitriou, Athanasia, Wallace, Derek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071315/
https://www.ncbi.nlm.nih.gov/pubmed/32658250
http://dx.doi.org/10.1093/infdis/jiaa406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071315/
https://www.ncbi.nlm.nih.gov/pubmed/32658250
http://dx.doi.org/10.1093/infdis/jiaa406

Ejemplares similares